Federal Register of Legislation - Australian Government

Primary content

PB 60 of 2021 Other as made
This instrument amends the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 to make changes to the pharmaceutical benefits listed on the Pharmaceutical Benefits Scheme and related matters.
Administered by: Health
Registered 30 Jun 2021
Tabling HistoryDate
Tabled HR03-Aug-2021
Tabled Senate03-Aug-2021
Date of repeal 19 Oct 2021
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

Pharmaceutical Benefits Advisory Committee




Email:                    PBAC@health.gov.au                                                                       Address all mail to:

                                                                                                                                                PBAC Secretariat

                                                                                                                                                GPO Box 9848

                                                                                                                                                Canberra  ACT 2601



EFFECTIVE 1 July 2021


Following is the advice of the Pharmaceutical Benefits Advisory Committee concerning the deletion of items from the declaration under subsections 85(2) and 85(2A) of the National Health Act 1953, with effect from the above date.



PBAC Advice


Interferon alfa-2a























The sponsor requested the deletion of all strengths of interferon alfa-2a injections.

The PBAC considered that the deletion would not result in an unmet clinical need.



Vanessa McMahon


PBAC Assessment Section

Office of Health Technology Assessment

Technology Assessment and Access Division

 16 June 2021